zileuton

Also found in: Medical.
(redirected from Zyflo)

zi·leu·ton

 (zī-lo͞o′tn)
n.
A drug that inhibits leukotriene formation, used to treat asthma.

[(ben)z(oth)i(ene), one of its components + leu(ko)t(riene) + -on.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive
Pratico's team gave Zyflo (zileuton) to mice genetically engineered to develop tau tangles .
To this day, zileuton (1) (Zyflo) remains the only 5-LO inhibitor approved for use by clinicians to help alleviate symptoms associated with asthma [11, 12].
Medications commonly used to treat asthma include corticosteroids (inhaled and oral), leukotriene antagonists (Singulair, Accolate, and Zyflo), theophylline, bronchodilators (both short- and long-acting), and xolair (Omalizumab).
If these cognitive symptoms bother you, speak to your health care provider, who may adjust dosage levels or suggest alternative drugs such as leukotriene modifiers (Singulair; Zyflo), mast cell stabilizers (Crolom; Nasalcrom; Tilade), or the antibody omalizumab (Xolair), which prevents the release of inflammatory chemicals that narrow the airways.
(Cary NC) alleging that the company's promotional materials withheld information about the risks of its asthma drug Zyflo CR.
There are two other members of this class of medications, zafirlukast (Accolate) and zileuton (Zyflo).
The oral medications that patients in the study were using were the leukotriene modifiers zafirlukast (Accolate), montelukast (Singulair), and zileuton (Zyflo).
The drugs affected by the FDA announcement include montelukast (Singulair), zafirlukast (Accolate) and zieuton (Zyflo and Zyflo CR).
The agency said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR).
The FDA, which issued the call in mid June, said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR).
Zileuto - Zileuton, also known as Zyflo CR, extended release, is an orally active inhibitor of 5-LO.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.